Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04064138
Other study ID # MS / 19.01.436
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2019
Est. completion date October 1, 2019

Study information

Verified date December 2019
Source Mansoura University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to detect weather peritoneal block or erector spinae plane block will provide the most ideal analgesia for patients undergoing laparoscopic cholecystectomy. Peritoneal block by instillation of local anesthetic into the peritoneal cavity will act by blocking the free afferent nerve endings in the peritoneum and the systemic absorption of local anesthetic from the peritoneal cavity may also play a part in reduced pain.

On the other hand ,the erector spinae plane block is a novel analgesic technique that provide both visceral and somatic analgesia due to its communication with the paravertebral space. Local anesthetic mixture of lidocaine , magnesium sulphate and epinephrine will be used for both techniques.


Description:

The pain that a patient feels after laparoscopic cholecystectomy results from three different and clinically separate components: somatic pain due to trocar insertion sites , visceral pain due to surgical dissection and tissue handling at the gall bladder bed, and shoulder pain due to retention of carbon dioxide in the abdomen, which irritates the phrenic nerve and diaphragm. Ineffective treatment of post laparoscopic cholecystectomy pain may delay recovery and mandate inpatient admission and therapy and increase the cost of such care.

The aim of this study is to evaluate the analgesic effect of Erector spinea plane block in comparison with peritoneal block for laparoscopic cholecystectomy. Serum level of cortisol as a stress biomarker ,perioperative primary hemodynamics ,visual analogue scale , patient request for rescue analgesia and occurrence of side effects are the parameters for comparison between both techniques. Each patient will be followed up for 24 hours postoperatively.


Recruitment information / eligibility

Status Completed
Enrollment 52
Est. completion date October 1, 2019
Est. primary completion date October 1, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- American physical status classes I and II

Exclusion Criteria:

- Patient refusal.

- Pregnancy

- Neuromuscular diseases (as myopathies, myasthenia gravies…)

- Hematological diseases.

- Bleeding diseases.

- Coagulation abnormality.

- Psychiatric diseases.

- Local skin infection at site of the block.

- Local skin sepsis at site of the block.

- Known intolerance to the study drugs.

- Body Mass Index > 40 Kg/m2.

- Chronic renal disease.

- Chronic hepatic disease.

- Preexisting neurological deficit.

- Conversion to open cholecystectomy

- Excessively long surgical times (> 90 min)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Peritoneal block
At the beginning of surgery, immediately after insertion of the first port 2 mg/kg lidocaine and 25mg/kg magnesium sulfate and 1/200 000 epinephrine in a total volume 50 ml (completed with saline .9%) will be given intra-peritoneal 10 min before the surgeon proceeds . At the end of the surgery another similar lidocaine-magnesium-epinephrine injection will be instillated before removal of the last port and the drain will be kept closed for 30 min.
Ultrasound guided erector spinae plane block
Before general anesthesia, ESPB will be performed under ultrasound guidance. The linear ultrasound transducer will be placed in a longitudinal parasagittal orientation 3 cm lateral to the T9 spinous process. The erector spinae muscles will be identified superficial to the tip of the T9 transverse process. The patient's skin will be anesthetized with 3 mL of 2% lidocaine. A 21 gauge 10cm needle will be inserted using an in plane superior to inferior. The tip of the needle will be placed into the facial plane on the deep aspect of erector spinae muscle. The location of the needle tip will be confirmed by visible fluid spread lifting erector spinae muscle off the bony shadow of the transverse process on ultrasonographical imaging. The calculated dose of lidocaine (2mg/kg) with 150 mg MgSo4 and 1/200 000 epinephrine will be injected on each side.
Other:
General anesthesia
General anesthesia

Locations

Country Name City State
Egypt Mansoura University, Central Hospital, gastroenterology surgery centre Mansoura DK

Sponsors (1)

Lead Sponsor Collaborator
Mansoura University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time for first requirement of rescue analgesia an analgesic (nalbuphine 10 mg ) will be administer postoperatively on patient request in case of the pain score = 4/10 on VAS. It represent the end point of the study which determines the duration of analgesia for 24 hours after surgery
Secondary Peripheral oxygen saturation estimate of oxygenated hemoglobin concentration in the blood , measured by pulse oximeter device one hour before induction general anesthesia then every 10 min till end of surgery then every 4 hours till end of first 24 hours.
Secondary mean arterial blood pressure The average pressure in the arteries during one cardiac cycle. one hour before induction general anesthesia then every 10 min till end of surgery then every 4 hours till end of first 24 hours.
Secondary heart rate Number of heart beats per minute. Lower heart rate implies better cardiovascular fitness and less stress. one hour before induction general anesthesia then every 10 min till end of surgery then every 4 hours till end of first 24 hours.
Secondary end tidal CO2 amount of carbon dioxide in each breathe . immediately after intubation and ever 10 min till the end of surgery.
Secondary Intensity of Abdominal Pain: visual analogue scale Postoperative assessment of abdominal pain using visual analogue scale (1-10), where 1 equals no pain and 10 indicates the worst possible pain. immediately after recovery ,then every 4 hours for 24 hour.
Secondary Intensity of Shoulder Pain: five point scale shoulder pain score scale:
no pain( the best outcome)
discomfort in shoulder but no pain
light pain ( analgesia not required)
moderate pain ( analgesia required)
sever pain ( analgesia and sedation required ) (the worst outcome)
immediately after recovery ,then every 4 hours for 24 hour.
Secondary serum cortisol level a steroid hormone secreted from adrenal cortex in response to stress. preoperative and one hour postoperative.
Secondary Post-operative total analgesic requirement total amount of nalbuphine consumed by the patient from the time of first analgesic requirement till the end of 24 hours. for 24 hours postoperatively.
Secondary nausea four point verbal rating score to assess the incidence of nausea and vomiting where 1 indicate they did not happen , 2 indicate nausea and 3 indicate vomiting for once and 4 indicate repeated vomiting immediately after recovery and every 4 hours for 24 hour postoperatively
Secondary vomiting four point verbal rating score to assess the incidence of nausea and vomiting where 1 indicate they did not happen , 2 indicate nausea and 3 indicate vomiting for once and 4 indicate repeated vomiting. immediately after recovery and every 4 hours for 24 hour postoperatively
Secondary dizziness a questionnaire will be collected to detect the incidence of occurrence of dizziness immediately after recovery and every 4 hours for 24 hour postoperatively
Secondary tinitus a questionnaire will be collected to detect the incidence of occurrence of tinnitus immediately after recovery and every 4 hours for 24 hour postoperatively
Secondary circumoral numbness a questionnaire will be collected to detect the incidence of occurrence of circumoral numbness immediately after recovery and every 4 hours for 24 hour postoperatively
See also
  Status Clinical Trial Phase
Completed NCT03670849 - Image Fusion in the OR N/A
Withdrawn NCT04561583 - Effectiveness and Safety of LED Light Source System for Endoscope N/A
Completed NCT00872287 - Pain in Single Incision Laparoscopic Surgery Cholecystectomy Phase 4
Recruiting NCT06017167 - Prophylaxis Against Postoperative Nausea and Vomiting After Laparoscopic Cholecystectomy Phase 2
Completed NCT05536557 - Bilateral External Oblique İntercostal (EOI) Plane Block in Patients Undergoing Laparoscopic Cholecystectomy. N/A
Recruiting NCT05794503 - Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex Early Phase 1
Completed NCT05998317 - Dexamethasone at Night vs at Induction on PONV After Laparoscopic Cholecystectomy Phase 2/Phase 3
Completed NCT04759079 - The Effects of Acupuncture Against Postoperative Nausea and Vomit After Laparoscopic Cholecystectomy N/A
Recruiting NCT04138472 - Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy N/A
Recruiting NCT06022926 - Investigation of the Intraoperative and Postoperative Effects of Warming Patients in Laparoscopic Cholecystectomy N/A
Completed NCT02469831 - Respiratory Mechanics and Metabolic Changes During Low Pressure Laparoscopic Cholecystectomy Phase 2
Completed NCT03067038 - Single Incision Versus Three Port Laparoscopic Cholecystectomy N/A
Completed NCT00886210 - Clinical Impact of Routine Abdominal Drainage After Laparoscopic Cholecystectomy N/A
Completed NCT00292214 - Comparing Intravenous and Oral Paracetamol for Cholecystectomy Phase 4
Recruiting NCT05533567 - Electroencephalographic Profiles During General Anesthesia: a Comparative Study of Remimazolam and Propofol N/A
Recruiting NCT05533580 - Differential Effects of Remimazolam and Propofol on Dynamic Cerebral Autoregulation During General Anesthesia N/A
Active, not recruiting NCT05636475 - The Effect Of Machine-Based And Manually Applied Hand Massage On Pain, Anxiety And Gastrointestinal System Functions After Laparoscopic Cholecystectomy Surgery N/A
Recruiting NCT05094193 - Trocar-site Infiltration Versus TAP-block N/A
Completed NCT03323684 - Quadratus Lumborum Block vs Transversus Abdominis Plane Block for Post-cholecystectomy Analgesia N/A
Recruiting NCT04162106 - Feasibility of the Ultravision™ System in Low Pressure Laparoscopic Cholecystectomy Compared to Airseal® IFS N/A